IL92257A0 - Binding proteins for insulin-like growth factors,pharmaceutical compositions containing them and dna fragments encoding them - Google Patents

Binding proteins for insulin-like growth factors,pharmaceutical compositions containing them and dna fragments encoding them

Info

Publication number
IL92257A0
IL92257A0 IL92257A IL9225789A IL92257A0 IL 92257 A0 IL92257 A0 IL 92257A0 IL 92257 A IL92257 A IL 92257A IL 9225789 A IL9225789 A IL 9225789A IL 92257 A0 IL92257 A0 IL 92257A0
Authority
IL
Israel
Prior art keywords
insulin
growth factors
pharmaceutical compositions
compositions containing
dna fragments
Prior art date
Application number
IL92257A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL92257A0 publication Critical patent/IL92257A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL92257A 1988-11-11 1989-11-09 Binding proteins for insulin-like growth factors,pharmaceutical compositions containing them and dna fragments encoding them IL92257A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888826451A GB8826451D0 (en) 1988-11-11 1988-11-11 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
IL92257A0 true IL92257A0 (en) 1990-07-26

Family

ID=10646720

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92257A IL92257A0 (en) 1988-11-11 1989-11-09 Binding proteins for insulin-like growth factors,pharmaceutical compositions containing them and dna fragments encoding them

Country Status (16)

Country Link
EP (1) EP0369943B1 (da)
JP (1) JPH0341096A (da)
AT (1) ATE112311T1 (da)
AU (1) AU623447B2 (da)
CA (1) CA2002609A1 (da)
DE (1) DE68918556D1 (da)
DK (1) DK564989A (da)
FI (1) FI895346A0 (da)
GB (1) GB8826451D0 (da)
HU (2) HU895607D0 (da)
IL (1) IL92257A0 (da)
MY (1) MY104673A (da)
NZ (1) NZ231333A (da)
PL (1) PL162290B1 (da)
PT (1) PT92278B (da)
ZA (1) ZA898610B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
CA2090703A1 (en) * 1990-08-28 1992-03-01 Michael C. Kiefer Insulin-like growth factor binding protein (igfbp-4)
EP0546074B1 (en) * 1990-08-28 2001-11-14 Chiron Corporation Genetic material encoding igfbp-5
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
EP0556344B1 (en) 1991-01-08 2003-08-13 Chiron Corporation New insulin-like growth factor binding protein
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
EP0708655A1 (en) * 1993-04-07 1996-05-01 Amgen Boulder Inc. Methods of using insulin-like growth factor binding proteins
ES2241906T3 (es) * 1993-09-20 2005-11-01 Celtrix Pharmaceuticals, Inc. Tratamiento de trastornos inmunologicos y hematologicos con igfbp solo o asociado con igf.
SE9303784D0 (sv) * 1993-11-16 1993-11-16 Kabi Pharmacia Ab Igf
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
DE60016560T2 (de) 1999-01-06 2005-12-15 Genentech, Inc., South San Francisco Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i)
WO2000040612A1 (en) 1999-01-06 2000-07-13 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
DK1282437T3 (da) 2000-05-16 2008-06-30 Genentech Inc Behandling af brusklidelser
AU2002248609B2 (en) 2001-03-14 2007-03-01 Genentech, Inc. IGF antagonist peptides
JP2007535895A (ja) 2003-05-01 2007-12-13 イムクローン システムズ インコーポレイティド ヒトインシュリン様成長因子−１受容体に対する完全ヒト抗体
CN102861321A (zh) 2003-09-12 2013-01-09 特西卡股份有限公司 胰岛素样生长因子-1(igf-1)缺陷的治疗方法
WO2005033132A2 (en) 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
BRPI0611984A2 (pt) 2005-06-17 2009-07-07 Imclone Systems Inc uso de anticorpos igf-ir para fabricação de um medicamento para tratar um tumor ósseo
WO2007092453A2 (en) 2006-02-03 2007-08-16 Imclone Systems Incorporated Igf-ir antagonists as adjuvants for treatment of prostate cancer
PE20201166A1 (es) 2017-09-11 2020-10-28 Shire Human Genetic Therapies Metodos y composiciones para tratar enfermedades pulmonares cronicas
TW202233228A (zh) 2020-10-19 2022-09-01 美商舒爾人類基因療法公司 適用於新生兒的組成物
CN118574840A (zh) 2022-01-19 2024-08-30 奥克希尔生物有限公司 用于减少igf-1/igfbp的氧化的组合物和方法
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
WO2024170612A1 (en) 2023-02-14 2024-08-22 Oak Hill Bio Limited Treatment of healing dysregulation in gi tissue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity

Also Published As

Publication number Publication date
HU895836D0 (en) 1990-01-28
HU895607D0 (en) 1990-01-28
JPH0341096A (ja) 1991-02-21
CA2002609A1 (en) 1990-05-11
ZA898610B (en) 1991-07-31
DK564989D0 (da) 1989-11-10
HUT53936A (en) 1990-12-28
PT92278A (pt) 1990-05-31
PT92278B (pt) 1995-09-12
AU4453689A (en) 1990-06-07
FI895346A0 (fi) 1989-11-09
EP0369943A1 (en) 1990-05-23
NZ231333A (en) 1992-10-28
PL162290B1 (pl) 1993-09-30
ATE112311T1 (de) 1994-10-15
EP0369943B1 (en) 1994-09-28
DE68918556D1 (de) 1994-11-03
MY104673A (en) 1994-05-31
AU623447B2 (en) 1992-05-14
DK564989A (da) 1990-05-12
GB8826451D0 (en) 1988-12-14

Similar Documents

Publication Publication Date Title
IL92257A0 (en) Binding proteins for insulin-like growth factors,pharmaceutical compositions containing them and dna fragments encoding them
AU630950B2 (en) Fibronectin binding protein as well as its preparation
PL313256A1 (en) Protocadherine proteins and their applications
EP1175909A8 (en) Therapeutic methods and compositions based on serrate proteins and nucleic acids
IL92816A0 (en) Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
EP0294349A3 (en) A fibronectin binding protein as well as its preparation
AU3346289A (en) Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
GR3020997T3 (en) A collagen binding protein as well as its preparation
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
AU669947B2 (en) Process for preparing recombinant and synthetic peptides, and their use
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines
GB9226928D0 (en) Novel immunoglobulin binding proteins,process for their production & recombinant dna molecules coding therefor